You are here

  • Home
  • Archive
  • Volume 78, Issue 10
  • Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis

Article info

Article menu
Download PDFPDF
Juvenile idiopathic arthritis
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis

Authors

  1. Correspondence to Francesca Minoia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano 20122, Italy; francesca.minoia{at}policlinico.mi.it
View Full Text

Citation

Minoia F, Bovis F, Davì S on behalf of the Pediatric Rheumatology International Trials Organization, the Childhood Arthritis & Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group and the Histiocyte Society, et al
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis
Annals of the Rheumatic Diseases 2019;78:1357-1362.

Publication history

  • Received February 9, 2019
  • Revised June 24, 2019
  • Accepted June 25, 2019
  • First published July 11, 2019.
Online issue publication 
May 13, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.